Literature DB >> 16084870

Evaluating the role of exogenous luteinizing hormone in poor responders undergoing in vitro fertilization with gonadotropin-releasing hormone antagonists.

Karine Chung1, Lewis Krey, Joseph Katz, Nicole Noyes.   

Abstract

OBJECTIVE: To evaluate the importance of exogenous LH in poor responders undergoing IVF with GnRH antagonists.
DESIGN: Retrospective cohort study.
SETTING: University-based IVF center. PATIENT(S): All patients with a history of poor response to ovarian stimulation undergoing IVF with GnRH antagonists between September 2000 and August 2001. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Clinical pregnancy rates. RESULT(S): Two hundred forty GnRH-antagonist cycles were initiated in poor responders. One hundred fifty-three progressed to oocyte retrieval. Seventy-five patients received recombinant FSH (Rec) for ovarian stimulation, and 66 received hMG in combination with Rec. In patients aged <40 years, there were no significant differences in amount and duration of treatment, number of oocytes retrieved, and number of embryos between treatment groups. In patients aged > or =40 years, significantly fewer oocytes were retrieved in groups who received exogenous LH in their stimulation, resulting in significantly fewer fertilized embryos. Implantation and clinical pregnancy rates did not differ by treatment group. CONCLUSION(S): In poor responders undergoing IVF with GnRH antagonists, outcomes are comparable whether stimulation is achieved in the presence or absence of supplemental LH. Exogenous LH does not appear to be necessary to achieve pregnancy in these challenging patients and may be detrimental to older patients with a history of poor response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16084870     DOI: 10.1016/j.fertnstert.2005.02.028

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

Review 1.  Different ovarian stimulation protocols for women with diminished ovarian reserve.

Authors:  D Loutradis; P Drakakis; E Vomvolaki; A Antsaklis
Journal:  J Assist Reprod Genet       Date:  2007-11-22       Impact factor: 3.412

2.  Efficacy of low dose hCG on oocyte maturity for ovarian stimulation in poor responder women undergoing intracytoplasmic sperm injection cycle: a randomized controlled trial.

Authors:  Tahereh Madani; Ladan Mohammadi Yeganeh; Shabnam Khodabakhshi; Mohammad Reza Akhoond; Fatemeh Hasani
Journal:  J Assist Reprod Genet       Date:  2012-09-07       Impact factor: 3.412

3.  Results from adding recombinant LH for assisted reproductive technology treatment: A randomized control trial.

Authors:  Mohammad-Hossein Razi; Fereshteh Mohseni; Razieh Dehghani Firouzabadi; Sima Janati; Nahid Yari; Sahabeh Etebary
Journal:  Iran J Reprod Med       Date:  2014-02

4.  Comparison of FSH and hMG on ovarian stimulation outcome with a GnRH antagonist protocol in younger and advanced reproductive age women.

Authors:  Chisa Tabata; Toshihiro Fujiwara; Miki Sugawa; Momo Noma; Hiroki Onoue; Maki Kusumi; Noriko Watanabe; Takako Kurosawa; Osamu Tsutsumi
Journal:  Reprod Med Biol       Date:  2014-07-11

5.  Independent Variables for Determining the Cumulative Live Birth Rates of Aged Patients with Polycystic Ovary Syndrome or Tubal Factor Infertility: A Retrospective Cohort Study.

Authors:  Yichun Guan; Pingping Kong; Zhiying Xiao; Junyan Zhang; Jingfang He; Wenjun Geng; Junfang Yan; Simin Sun; Mingkun Mu; Xiaofang Du; Xingling Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-17       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.